The Role of Nitric Oxide (Formerly Endothelium-Derived Relaxing Factor-EDRF) in Vasodilatation and Vasodilator Therapy
- 1 December 1993
- journal article
- review article
- Published by SAGE Publications in Anaesthesia and Intensive Care
- Vol. 21 (6) , 759-773
- https://doi.org/10.1177/0310057x9302100604
Abstract
Subscription and open access journals from SAGE Publishing, the world's leading independent academic publisher.Keywords
This publication has 113 references indexed in Scilit:
- Inhaled Nitric Oxide for the Adult Respiratory Distress SyndromeNew England Journal of Medicine, 1993
- Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in SheepAnesthesiology, 1991
- Endothelium-derived relaxing factorPharmacology & Therapeutics, 1989
- L-Arginine is a precursor for nitrate biosynthesis in humansBiochemical and Biophysical Research Communications, 1989
- The discovery of nitric oxide as the endogenous nitrovasodilator.Hypertension, 1988
- Quantitative and kinetic characterization of nitric oxide and EDRF released from cultured endothelial cellsBiochemical and Biophysical Research Communications, 1988
- ENDOTHELIUM-DERIVED RELAXING FACTOR RELEASED FROM CULTURED CELLS: DIFFERENTIATION FROM NITRIC OXIDEClinical and Experimental Pharmacology and Physiology, 1988
- Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats.Hypertension, 1987
- Increased vasoconstrictor activity of proximal coronary arteries with endothelial damage in intact dogs.Circulation, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980